Surface battery testing and estimated performance

Surface Laptop 4 13.5 AMD Ryzen 5 Microsoft Surface Edition processor 8 GB RAM

Up to 19 hours of battery life based on typical Surface device usage

Testing conducted by Microsoft in February 2021 using preproduction software and preproduction 13.5 AMDRyzen5 Microsoft SurfaceEdition processor, 8GB RAM device. Testing consisted of full batterydischargewith a mixture of active use and modern standby. The active use portion consists of (1) a web browsing test accessing 8 popular websites over multiple open tabs, (2) a productivity test utilizing Microsoft Word, PowerPoint, Excel, and Outlook, and (3) a portion of time with the device in use with idle applications. All settingsweredefault except screen brightness was set to 150nits with Auto-Brightness disabled.Wi-Fi was connected toanetwork.Battery life varies significantly with settings,usage,and other factors.

Surface Laptop 4 15 AMD Ryzen 7 Microsoft Surface Edition processor 8 GB RAM

Up to 17.5 hours of battery life based on typical Surface device usage

Testing conducted by Microsoft in February 2021 using preproduction software and preproduction 15 AMD Ryzen 7 Microsoft Surface Edition processor, 8GB RAM device. Testing consisted of full battery discharge with a mixture of active use and modern standby. The active use portion consists of (1) a web browsing test accessing 8 popular websites over multiple open tabs, (2) a productivity test utilizing Microsoft Word, PowerPoint, Excel and Outlook, and (3) a portion of time with the device in use with idle applications. All settings were default except screen brightness was set to 150nits with Auto-Brightness disabled. Wi-Fi was connected to a network. Battery life varies significantly with settings, usage and other factors.

Surface Laptop 4 13.5 Intel Core i5 512GB, 8 GB RAM

Up to 17 hours of battery life based on typical Surface device usage

Testing conducted by Microsoft in February 2021 using preproduction software and preproduction 13.5 Intel Core i5, 512GB, 8 GB RAM device. Testing consisted of full battery discharge with a mixture of active use and modern standby. The active use portion consists of (1) a web browsing test accessing 8 popular websites over multiple open tabs, (2) a productivity test utilizing Microsoft Word, PowerPoint, Excel and Outlook, and (3) a portion of time with the device in use with idle applications. All settings were default except screen brightness was set to 150nits with Auto-Brightness disabled. Wi-Fi was connected to a network. Battery life varies significantly with settings, usage and other factors.

Surface Laptop 4 15 Intel Core i7 512GB, 16 GB RAM

Up to 16.5 hours of battery life based on typical Surface device usage

Testing conducted by Microsoft in February 2021 using preproduction software and preproduction 15 Intel Core i7, 512GB, 16 GB RAM device. Testing consisted of full battery discharge with a mixture of active use and modern standby. The active use portion consists of (1) a web browsing test accessing 8 popular websites over multiple open tabs, (2) a productivity test utilizing Microsoft Word, PowerPoint, Excel, and Outlook, and (3) a portion of time with the device in use with idle applications. All settings were default except screen brightness was set to 150nits with Auto-Brightness disabled. Wi-Fi was connected to a network. Battery life varies significantly with settings, usage and other factors.

Here is the original post:
Surface battery testing and estimated performance

Make it easier to focus on tasks – Microsoft Support

Windowsoffers lots of ways to minimize distractions so it's easier to focus on tasks. You can declutteryour taskbar and simplify the Start menu, use Focus to manage your notifications, and use the Immersive Readerto minimize visual distractions when reading a web page inMicrosoft Edge.

Minimize visual distractions by turning off animations, background images, and more.

Select Start> Settings> Accessibility > Visual effects.

To minimize distractions, do one or more of the following:

To automatically hide the scrollbars in Windows,turn off the Always show scrollbars switch.

To make some window backgrounds more opaque,turn off the Transparency effectsswitch.

If you don't want Windowsto show animations, turn off the Animation effectsswitch.

To define how long notifications are shown, expand theDismiss notifications after this amount of timemenu and select the option you want.

Choose which icons appear on the taskbar and reduce the number of items in view.

Select Start> Settings> Personalization> Taskbar.

SelectTaskbar items and Taskbar corner iconsto expand those sections andturn off the switches for the items you don't want to see on the taskbar.

To select which icons can appear in the taskbar corner, select Taskbar corneroverflow. Turn on the switches for the icons that you want tosee in the taskbar corner. The icons with the switches turned off won't show directly on the taskbarthey'll onlyappear in the taskbar corner overflow menu.

Do not disturballows you to define which notifications you see and hear and when. The rest of the notifications will go to the notification center where you can see them any time.

You can also modify the notifications settings to choose which apps display notifications.

Select Start> Settings> System > Notifications, then adjust the settings.

To see and hear fewer notifications, turn on Do not disturb.

If you want to choose notifications from certain apps, select Set priority notifications. Modify theseoptions to get the notifications you want to see when do not disturb is turned on.

Tip:To quickly switchDo not disturbon, go to the taskbar and select thebattery, network, or volume icon to open the notification center, then turn it on or off.

Select Start> Settings> System > Notifications.

InTurn on do not disturb automatically, selectDuring these times to turn it on.

Choose when do not disturb turns on, turns off, and how often it repeats.

You can also choose the types of tasks that will turn on do not disturb automatically.

If notifications are distracting when they appear on your screen, adjust which apps display notifications and fine-tune how they appear.

Select Start> Settings> System > Notifications.

InNotifications from apps and other senders, turn off the apps you don't wantnotifications from and turn on the apps you do want to get notifications from.

To define where the notifications appear for each app, select a specific app, then change the options as desired.

To read a web page on a simpler and cleaner layout, use the Immersive ReaderinMicrosoft Edge. For more info on theImmersive Reader, go toUse Immersive Reader in Microsoft Edge.

To start using the Immersive Reader, open the web page you want to read inMicrosoft Edge, and then press the function key + F9. Alternatively,select (Enter Immersive Reader) on the address bar.

Tip:If you dont see the (Enter Immersive Reader) icon on the address bar, select the text you want to read, right-click,and selectOpen selection in Immersive Reader.

The page opens on a simpler layout. To change how the page is displayed, review the options on the toolbar at the top of the page. Under Text preferences, for example, you can modify the background color using themesor change the font.

To exit the Immersive Reader, select (Exit Immersive Reader) ontheaddress bar orpress the function key + F9.

Windowsoffers lots of ways to minimize distractions so it's easier to focus on tasks. You can declutteryour taskbar and simplify the Start menu, use Focus assistto manage your notifications, and use the Immersive Readerto minimize visual distractions when reading a web page inMicrosoft Edge.

Minimize visual distractions by turning off animations, background images, and more.

SelectStart , then select Settings > Ease of Access > Display.

Choose from the different options underSimplify and personalize Windows.

Choose which icons appear on the taskbar and reduce the number of items in view.

SelectStart , then select Settings > Personalization > Taskbar .

Under Notification area, choose Select which icons appear on the taskbar.

System icons, like the clock and battery indicator, can also be turned on or off.

Select Start , then select Settings > Personalization .

Under Notification area, choose Turn system icons on or off.

Many apps use Live Tiles to show updates on what's happening in your world, like new email, your next appointment, or the weekend weather. If these animations are distracting, you can turn them off.

Press and hold (or right-click) a tile, and then select More > Turn Live Tile off.

Focus assist (also called quiet hours in earlier versions of Windows 10) allows you to avoid distracting notifications when you need to stay focused.It'sset by default to activate automatically under certain conditions.

Here's how to turn focus assiston or off:

Select the Action Center icon on the taskbar.

Select Focus assist to cycle through the available settings: either Priority only, Alarms only, or Off.(If you don't see the Focus assist tile, you may need to select Expand first.)

Focus assist settings can be editedby selecting Start >Settings> System> Focus assist. Or you cantype Focus assist into the search boxon the taskbar, and then select Focus assist settingsfromthe list of results.

In the Focus assist settings, you can limit late-night notifications using the Automatic rules section. To do that, select During these times and turn on the toggle. Then, selectStart timeorEnd time, picka time, and select the check markto save your changes. You can also choose what days you want to apply the rule, and what types of notifications you'd still like to receive during the times you set.

Open focus assist settings

If notifications are distracting when they appear on your screen, adjust which apps display notifications and fine-tune how they appear. To change notification settings, selectStart , then select Settings > System > Notifications & actions . You can then choose which types of notifications you want to see.

For a clean and simple layout, use Reading view in the Microsoft Edge browser address bar to bring whatever you're reading front and center. After you open an article, you'll see abook icon on the right side of your browser. When you select it, you'll be in reading view.

Go here to see the original:
Make it easier to focus on tasks - Microsoft Support

Maximize your Surface battery life – Microsoft Support

Your Surface uses an internal lithium-ion battery. The amount of time your battery lasts will vary depending on the kinds of things you do with your Surface. This article will help you learn more about how to get the most out of your Surface battery.

On some Surface models you can select a power mode, which affects how much battery life and the performance you can get from your Surface.

To switch to a different power mode, disconnect the power supply (if it's plugged in),select Start > Settings > System > Power & battery > Power mode. If you want to save power to write an email or finish watching a movie, move the slider to a lower setting, like Recommended or Battery saver. Or, if you need better performance for playing a game or using a Windows Mixed Reality headset, move the slider to a higher setting (like Best performance).

Use the detailed Battery information in Windows to see which apps are using the battery power.

Select Settings > System > Power and battery.

Open Power & battery settings

For Battery levels, select Last24 hours, and then selectan hour of high battery usage.

For Show, select Apps with usage.

Look for apps that are using a lot of battery power. If you're not using them, you should close those unused apps.

If the apps start automatically, open Task Manager and then select the Startup tab. For any apps, you don't want to start automatically, you can select the app, then select Disable. For more info see Change which apps run automatically at startup in Windows.

If you're using the apps that usea lot of battery power, you might want to plug in your Surface while using those apps to help get the most from your battery over time.

For ways to save battery power, including how to find out which apps are using the most battery,see Battery saving tips for Windows.

Installing the latest updates will help keep your Surface performing at its best. SelectCheck for Windows updatesbelow to open Windows Update in Settings.

Check for Windows updates

Your Surface uses an internal lithium-ion battery. The amount of time your battery lasts will vary depending on the kinds of things you do with your Surface. This article will help you learn more about how to get the most out of your Surface battery.

On some Surface models you can select a power mode, which affects how much battery life and the performance you can get from your Surface.

To switch to a different power mode, disconnect the power supply (if it's plugged in), select the Battery icon on the right side of the taskbar.If you want to save power to write an email or finish watching a movie, move the slider to a lower setting, like Recommended or Battery saver. Or, if you need better performance for playing a game or using a Windows Mixed Reality headset, move the slider to a higher setting (like Best performance).

Use the detailed Battery information in Windows to see which apps are using the battery power.

Open Settings > System > Battery, and then See which apps are affecting your battery life.

For Time period, select 6 hours, 24 hours, or 1 week (depending on which time period has a higher amount of battery usage).

For Show, select Apps with usage.

Look for apps that are using a lot of battery power. If you're not using them, you should close those unused apps.

If the apps start automatically, open Task Manager and then select the Startup tab. For any apps, you don't want to start automatically, you can select the app, then select Disable. For more info see Change which apps run automatically at startup in Windows.

If you're using the apps that usea lot of battery power, you might want to plug in your Surface while using those apps to help get the most from your battery over time.

For ways to save battery power, including how to find out which apps are using the most battery,see Battery saving tips for Windows.

Installing the latest updates will help keep your Surface performing at its best. SelectCheck for Windows updatesbelow to open Windows Update in Settings.

Check for Windows updates

Visit link:
Maximize your Surface battery life - Microsoft Support

Celebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry – Forbes

Michael Ringel, PhD, JD, Managing Director & Senior Partner, Boston Consulting Group (BCG), ... [+] presenting at the 9th Aging Research and Drug Discovery meeting organized by the University of Copenhagen and Insilico Medicine. Presentation title "The Emerging Commercial Landscape for Aging Biology-Based Therapeutics"

While I had very high expectations traveling to the 9th Aging Research and Drug Discovery (ARDD) forum, the largest five-day annual gathering of the longevity biotechnology industry organized by the University of Copenhagen, the event did not fail to impress. I can spend endless hours covering the lectures of top-tier academics, pharmaceutical industry leaders, and venture capitalists, but these would be better covered in the conference proceedings. However, one lecture titled The Emerging Commercial Landscape for Aging Biology-Based Therapeutics by Dr. Michael Ringel, captivated even the most experienced industry executives and the established aging researchers.

Dr. Michael Ringel at the 9th ARDD conference

The sheer fact that Boston Consulting Group (BCG), the worlds most venerated consulting firm specializing primarily in strategy and management consulting, became a knowledge partner of the ARDD indicates that the meeting has reached a certain level of credibility and longevity biotechnology is a clear trend. BCG is known for being very impartial, knowledge- and experience-driven, and providing valuable strategic insights to the boards and CEOs of the worlds largest corporations. The firm is used by governments all around the world when they want to get deep industry insights or when they want to formulate a national strategy around a specific trend. From what I know, BCG was used by the Kingdom of Saudi Arabia to help formulate their famous Longevity Strategy, which resulted in the creation of the $1 Billion a year non-profit, Hevolution Foundation.

Dr. Michael Ringel, BCG presenting at the 9th ARDD in Copenhagen

One differentiating feature of BCG is the quality of its slides. They often manage to turn a very complicated story into a set of visually appealing, easy-to-comprehend slides that provide a clear problem definition, recommendation, situation assessment, and alternatives. These slides are rarely shared by the customers as they usually represent a substantial investment and intellectual property.

Therefore, when during his 30-minute talk, Dr. Ringel went through over thirty of these valuable slides, those of us who understand the value made sure to get the recording of the lecture.

Here are some of the top takeaways from Dr. Ringels presentation that Im able to share:

Michael Ringel, PhD, JD, Managing Partner, BCG, presenting at the 9th Aging Research and Drug ... [+] Discovery meeting

I knew Dr. Michael Ringel prior to the ARDD as a well-known strategy and management consultant in the pharmaceutical industry. After almost 25 years at BCG in healthcare practice, he is on a first-name basis with every pharma CEO, board member, investor, and government official, and is a walking encyclopedia who also knows most of the emerging technologies and their applications.

From left to right: Eric Verdin, MD, CEO of the Buck Institute for Research on Aging, Mehmood Khan, ... [+] MD, CEO, Hevolution Foundation, Michael Ringel, PhD, JD, Managing Director, BCG, Alex Zhavoronkov, CEO, Insilico Medicine

Here, I asked Dr. Ringel a few questions to get his perspective on longevity biotechnology and the future of this exciting new field:

Alex Zhavoronkov: Michael, I know that aging biology is not only your professional focus but also your personal interest. What made you interested in this field?

Dr. Michael Ringel: Alex, thanks so much for having me. It truly is a pleasure to sit down with you. One disclosure before we start the discussion. One of the investors in your company, Insilico Medicine, is B Capital Group. My company, BCG, is a partner to B Capital Group, and so I have an indirect and small financial stake in your company that we need to mention.

As to my interest in the field, Ive spent my career working in healthcare, trying to help companies bring better medicines to people. And when I found out there is an area of biology that underpins not just one, but the majority of the chronic diseases that burden us, I realized the impact it might have on human health. Preventing multiple diseases with one intervention is a potential game-changer, if you can make it work. The key word being *if*. But when you dig into the science, you find out in fact theres really good evidence to support the notion. We just have to do the work to translate what weve seen in the lab to humans.

Alex Zhavoronkov: You have been in biopharma for over 25 years and you have seen everything. You saw Geron, Sirtris, ResTORbio, Unity, and many other companies in this area. How do you see the field of aging biology evolving and propagating into the biopharma industry and how did the field change over the past decade?

Dr. Michael Ringel: Understanding a new area of science can sometimes take a long time and then sometimes there are these great leaps forward. In my youth in the 70s we knew about caloric restriction, which is still one of the best-validated interventions. But we didnt know much about how it works. That began to change in the 90s, kicked off in part by Cynthia Kenyons seminal work in worms, as we began to understand the biological pathways involved. We saw the first pharmaceutical intervention proven to work in a mammal, in mice, just over a decade ago with the NIHs Interventions Testing Program. Today there is a small but growing pipeline of drug candidates in clinical testing. I believe we are on the cusp of the first demonstrated effective intervention in humans, which I believe will be one of those great leap-forward moments that galvanize interest in the field.

Alex Zhavoronkov: In your opinion, how long will it take the pharmaceutical industry to buy into the concept of utilizing aging biology as a platform for drug discovery for a range of therapeutic areas?

Dr. Michael Ringel: We are already seeing activity. We know from publicly available information that many companies have external partnerships or internal units, including AbbVie, Novartis, Regeneron, and others. For instance, UCB has partnered with your own company, Insilico Medicine. So it has already started. I believe that over the next decade, we will see a burgeoning pipeline focused on various pathways of longevity biology, and once the first clinical studies demonstrate proof-of-concept, we will really see interest grow.

Alex Zhavoronkov: Of course, you can not talk about Saudi Arabia and Hevolution since these are clients but I was one of the key opinion leaders interviewed for this project in 2019, and BCG was clearly involved. Why is longevity biotechnology so important for any emerging economy and do you think other countries should prioritize longevity in a similar way?

Dr. Michael Ringel:I cant give opinions on specific companies or foundations and would refer you to their leadership for questions about them. But as to the general point of why this matters all over the world, in developed and emerging economies, it is because it has the promise of being such a powerful way to improve human health. Weve seen that just throwing more money at the current healthcare system has not improved lifespan or healthspan, and we even have had retrograde motion in some areas, with lifespans declining. In part, that is due to the growing burden of metabolic disorders like diabetes. What we need is a better way, more focused on prevention an ounce of prevention is worth a pound of cure. And thats where longevity biology is critical. It is, at heart, a preventative approach. And the core pathways are the very same ones that are implicated in the metabolic disorders that are a growing issue all over the world.

Alex Zhavoronkov: What is your advice to the young entrepreneurs in this nascent longevity biotechnology industry?

Dr. Michael Ringel: Theres a lot that you need to do as an entrepreneur you need to figure out funding, build a team, set up operations, choose your preclinical and development plans, develop partnerships, and a million other things Im always incredibly impressed by how much thesel young entrepreneurs can accomplish, juggling all these things at once. But the sine qua non, the thing you cannot do without in biotech, is good science. All the rest of the work is built on the foundation of a good idea, a new way to help people. So my advice is make sure youre investing your time and energy getting as deep into the science as you can.

Alex Zhavoronkov: Finally, how did you like the ARDD conference, what were your major takeaways, and will you come again next year?

Dr. Michael Ringel: To me ARDD is a unique conference in longevity, bringing a heavyweight mix of the most impressive scientists in the field together with the most promising start-ups and a great set of investors. For anyone already in the field, it is the place to be, and for anyone looking to learn more, I cannot think of a better place to get a crash course. Particularly the large pharmaceutical companies would benefit by bolstering their attendance to get deeper into this field.

The 9th Aging Research and Drug Discovery meeting, Grand Hall, University of Copenhagen, September ... [+] 2022

Michael Ringel, PhD, JD, Managing Director and Senior Partner, Boston Consulting Group

Michael Ringel, PhD, JD, is Boston Consulting Group's global leader for innovation analytics and research and product development, and is a core member of the firms Corporate Finance & Strategy practice. Michael is a frequent contributor to industry journals, including Nature Reviews Drug Discovery, and has coauthored numerous BCG reports on innovation, R&D, and corporate strategy. He received a BA in biology from Princeton, a PhD in biology from Imperial College London, and a JD from Harvard Law School.

View post:
Celebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry - Forbes

3 Research-Backed Tips To Make Your Muscles Act Younger – mindbodygreen

"If you haven't trained with any focus by the time you're 30, you need to be," says Lyon. Everyone's body is different, but if you can, she recommends a combination of cardiovascular activity (specifically zone 2 training) and resistance training. Zone 2 training really just refers to any cardio workout that gets your heart pumping to the point where you can still hold a conversation, but it might be difficult to do so. "That zone 2 training is critical for mitochondria," notes Lyon. "It's important for glucose utilization for the foods that you're eating, and overall it provides a base."

However, it's not enough: "In your 30s, I really believe everybody should be doing three to four days a week of hypertrophy training," she adds. Hypertrophy training is all about increasing muscle mass, namely through weight training. "As opposed to [using] much heavier weight and lower volume, the volume is important," Lyon adds. (Meaning, more sets and reps with less intensity.) "This is really about growing your muscles," she notes, and strong muscles are crucial for sustaining longevity.

Continued here:
3 Research-Backed Tips To Make Your Muscles Act Younger - mindbodygreen

We might not know the future… but we can spot its longevity trends – Longevity.Technology

Yesterday, we brought you the first installment in our longevitys burning questions series, in which we ask some of the longevity heavyweights and pioneers speaking at the upcoming Longevity Investors Conference their views on some of the significant issues in the antiaging field.

Longevity.Technology: Longevity is on its way to becoming the most significant investment opportunity available; the Longevity Investors Conference targets the global investor community and brings a whole range of institutional investors together with top class and longevity-experienced speakers. Later this month they will together explore relevant insights into the field, expert education and investment opportunities, as well as enjoying excellent networking possibilities in the scenic and exclusive town of Gstaad.

Longevity.Technology readers can get their exclusive invitation to the leading investors-only longevity conferenceHERE.

Previously, we found out the LIC communitys views on the areas of the field of longevity that hold potential for the biggest improvement. Today, explore a couple of topics, the first being what our hivemind considers to be the current biggest trend in longevity and whats set to explode?

One of the foremost thinkers in the field, Dr Barzilai is the Director of The Institute of Aging Research at the Albert Einstein College of Medicine.

He told us that the biggest improvement is in the investment in gerotherapeutic biotech, which is estimated to be $40 billion by some.

It is the major driver in the field, Barzilai told us. It drew some billionaires to invest in moon shot projects, it will help raise money to complete the TAME trial that may cause a regulatory tsunami, and it also harbors some of the more unique biology targeting aging that we are discovering through the drug development rather than the scientificpapers.

Dr Brenner is the developer of the intellectual property behind ChromaDexs Tru Niagen. He told us that the biggest trend in longevity is to use biomarkers, such as GrimAge, toscore interventions.

As no one has shown that lowering a GrimAge score correlates with better functional outcomes, I am unconvinced of the utility of these biomarkers, he says. I like to stay away from things that explode and that is why I am alive and well and doing research.

Internet entrepreneur Michael Greve became a longevity trailblazer when he created the Forever Healthy Foundation.

He told us that: No one knows the future, but we invest in never-done-before approaches,that, if working, have a tremendous potential to be a desirable treatment for everyone over the age of 40.

As Director of the Centre for Healthy Longevity at the National University of Singapore, Dr Brian Kennedy is committed to translating research discoveries into new ways of delaying, detecting, preventing and treating human aging and associated age-related diseases.

In research, the big thing is now rejuvenation-based strategies, which arevery promising but still in the research stage, he told us.

I would also not discount gene therapy approaches in the medium term. This technology has been slowly evolving and is now being used to treat diseases, he said, adding that ultimately, targeting aging genetically may be an excellent strategy to extend healthspan and lifespan.

Dr Fortney is CEO of BioAge, a biotech on a mission to develop a pipeline of therapeutic assets that increase healthspan and lifespan.

Dr Fortney told us that cellular reprogramming has received a lot of attention lately, on multiple levels, including advances in academic research, the entry of multiple companies into the field, and the sheer size of investment by some big players.

Although the ideas are quite new and applications are likely to be far in the future, the promise of reprogramming for reversing age-related decline is enormous, she said, adding that although this area isnt currently a major focus for BioAge, they wish their colleagues in the cellular reprogramming field the best of luck as they start down the path toward developing therapeutics that can extend healthy lifespan.

As for whats set to explode what Im most excited about is the speed of clinical translation and the growing number of aging drugs that are entering clinical trials today, both at BioAge and at other companies in the longevity space, she said. Once we get the first few successful trials, well see an explosion of interest in an already rapidly growing sector.

Co-Founder of SENS Research Foundation, Dr de Grey has just announced his new research foundation.

When it comes to what constitutes a big trend, says de Grey, the answer differs greatly depending on ones perspective.

From the point of view of the Longevity Investors Conference delegates, I think the biggest trend is diversity and synergy, de Grey explains. Damage repair is inherently adivide-and-conquer strategy, in which big results will only be seen when multiple therapiesare given to the same people at the same time.

Dr de Grey believes that the smart money needs to go to those who are creating the framework for that the venture funds and holding companies whose portfolios have the potential to deliver truly transformational combination therapies.

As for whats set to explode, well, let me be a bit radical here and highlight cryonics, says de Grey.

Cryonics has had an even harder time than damage repair in being understood asa valid and promising medical research area, but we now have a very rapid growth in new players in that space, including providers like Tomorrow Biostasis and research outfits likeLorentz Bio, led by highly credentialed people in terms of both biomedical and commercialexpertise.

De Grey feels that the further we progress in developing rejuvenation biotech that really works, the more the world will want to take that bridge to the future.

A former ER doctor, Dr Killen is an antiaging and regenerative medicine physician who specialises in aesthetics and sexual medicine. She told us that as a stem cell physician, she can see great potential in regenerative therapies.

In the coming years, well see more and more allogeneic (the donor and patient are not thesame) stem cell therapies become available and well see products that are engineered tosolve specific problems, she told us. My hope is that these off the shelf cellular products will be widely available at a reasonable price so we can start to see the democratization of regenerative medicine.

Dr Martin Borch Jensen is the CSO of Gordian Biotechnology and the force behind the the successful Impetus Grants.

He told us that the biggest current trend has to be partial reprogramming, with Altos, Retro, NewLimit and other companies focusing on this approach to reversing cellular age.

Lets see how hard that turns out to be! he says.

I think something that will increasingly impact the aging field is high-throughput functionalgenomics coupled with active learning computational analysis Borch Jensen continued.

For example, running a pooled CRISPR screen to knock out genes in a population of cells, isolating cells that fail to turn senescent in response to normal stimuli, then sequencing the gRNAs to identify the target genes and repeating the screen with combinations of these targets. This approach is enabling work in cancer and other fields, and (with the right readouts) will do the same in aging.

Our second burning question concerned our panels longevity journey; we wanted to know what was the inspiration for their longevity point and has the journey been as expected?

Amy B Killen

Dr Killen was an emergency physician for ten years before becoming interested inlongevity medicine.

Ultimately, I was inspired by my patients, she told us, explaining that she saw the effects of aging and age-related diseases every day in the emergency department.

I saw the effects of lack of education and poor lifestyle choices, combined with limited access to resources and support from the medical establishment, she says, adding that she ultimately left the emergency department to make herself healthier and in doing so, discovered an entire field of study that is primed to restore vitality in all of us.

It took a little time for me to think of aging as a disease, but once I wrapped my head around it, I couldnt think of it in any other way!

Kristen Fortney

If we could cure all cancers, we would add just a few years to average lifespan, says Fortney, adding that the same goes for all cardiovascular disease, and the many other illnesses that become exponentially more common as we get older.

But if we could slow aging in humans to the same extent that weve already done over and over again in mice, we could extend longevity by decades, and most of those years would be healthy, she says. Likewise, from the many humans who already live past 100 in good health, we know there must be mechanisms that allow human bodies to enjoy dramatically longer lives.

This idea was one of the major inspirations for Fortney to found BioAge, a journey which, she says, has been exciting, to say the least!

Im constantly impressed by the rapid rate of scientific and now clinical progress in the aging field, Fortney adds, explaining that as more and more companies and scientific organisations join the fight and more resources enter the field, she sees that continuing into the future.

For more information, please visitwww.longevityinvestors.chor email[emailprotected]Or, bag your exclusive invitation to the leading investors-only longevity conferenceHERE.

Follow Longevity Investors Conference onLinkedIn/Twitter/Instagram

More here:
We might not know the future... but we can spot its longevity trends - Longevity.Technology

Nova Vita Redefines Longevity With Innovative Wellness Solutions – PRUnderground

Nova Vita Wellness Centers, whose parent company is Intiva Health, is redefining how patients view longevity with its innovative wellness solutions.

There is more to longevity than the number of candles on a birthday cake. Nova Vita Wellness Centers offers services which slow the progression of aging on the inside and on the outside.

An essential part of Nova Vitas mission is to help people achieve longer memories, enjoy longer activities, and prosper with longer happiness. Their wellness solutions are designed to help people feel better, look better, and be better so they can enjoy living a higher quality of life for many years to come.

Starting With the Basics:

Nova Vita Wellness Centers developed their own trifecta of longevity solutions. The building blocks of longevity boil down to whole-body health and wellness. The human body is made up of eight main systems that function independently and synergistically. Utilizing a comprehensive lab panel, Nova Vita can identify a persons specific needs to help all systems run like a well-oiled machine.

Innovative Wellness Solutions:

The journey to wellness doesnt have a final destination and new avenues to improved health are constantly being discovered. Nova Vita routinely updates their solutions based on the latest scientific evidence to provide clients with the foundations for longevity, contemporary services for optimal nutrition, and pathways for personal improvement. Their unique approach involves a combination of cellular therapy, 3D Body Scanning, advanced aesthetics, and customized vitamin formulations based on a persons specific needs.

IV Vitamin Infusions

There are 13 essential vitamins, 15 essential minerals, and a long list of amino acids that the human body needs for optimal function. The body can only synthesize a fraction of the optimal amount required of these vitamins, minerals, and amino acids. The rest are obtained by eating specific foods or dietary supplements. While a healthy diet is undoubtedly an important steppingstone for longevity, the body is only absorbing a small percentage of the nutrients a person consumeseven with traditional oral supplements.

IV Vitamin Infusions at Nova Vita provides the body with 100% of the vitamins within the formulation since it bypasses the digestive system. Each IV Vitamin Infusion is specially formulated to provide targeted benefits and address individual wellness journeys, allowing a person to choose an infusion specific to their needsfrom whole-body optimization to specific health concerns and vitamin deficienciesall of which boost longevity.

NAD+ Therapy

NAD+ is found naturally in all living cells and plays a crucial role in whole body health. As we get older, the levels of NAD+ in our body decreases which contributes to the leading causes of aging. An NAD+ Infusion directly provides the cells in your body with this important coenzyme to improve a range of bodily functions directly related to longevity.

Nova Vita Wellness Centers provides NAD+ Therapy both as a standalone treatment or an adjunct therapy to boost the effectiveness of its other wellness solutions.

About Nova Vita Wellness Centers

Nova Vita is a specialized health and wellness center, dedicated to bridging the gap traditional medicine left behind through the recovery, optimization and integrity of a persons physical and mental health through evidence-based advances in neuroscience and customized wellness solutions. Nova Vita offers dozens of IV vitamin infusion therapies, ketamine infusion therapy, and additional services tailored to the individual patient. Nova Vita opened their second Texas location just outside of Austin in 2021, doubled their wellness service offerings, and has plans for additional locations in Florida, Utah, Arizona, Illinois, and Nevada.

Read more from the original source:
Nova Vita Redefines Longevity With Innovative Wellness Solutions - PRUnderground

Prioritizing Equity Spotlight series: Centering restorative justice in health innovation – American Medical Association

This Prioritizing EquitySpotlight session is sponsored by the Robert Wood Johnson Foundation and the American Medical Association Foundation.

Over the past several years, there has been an increased awareness of the exclusionary policies and practices that have restricted and impacted the health innovation ecosystem for communities that have been historically marginalized and minoritized. These historical truths warrant restorative remedies to heal and reconcile past and current harms.

This session will explore restorative justice in the context of the health care innovation space and related policies, practices, politics and strategic opportunities to center healing and humanity in health care design and technology.

Keeys: All right. Good afternoon, everybody. Welcome. Well, welcome to us to the stage. I'm Mia Keeys and I'm so very glad to be joined today by all of you here. We're going to be talking about centering restorative justice within health innovation and I'm really quite honored to be joined by you all who are policymakers, whether you're tech innovators or C-suite level executives. All of you have quite the role with respect to standing up for restorative justice in your own practices and within your own communities.

During this session, as I've mentioned, we're uplifting restorative justice, and what we mean by that in the context of health care innovation and policymaking and practice refers to the collaborative approach that brings together those key constituents who have historically been marginalized or minoritized or just not a part of decision-making processes, bringing all of those persons together to bear on the decisions made around practices, policies that have historically been a part of different organizations and have been perpetuated by offending parties.

Now that definition was adapted from the American Association of Medical Colleges, also by the Restorative Justice Network, the UN Human Rights Commission and finally from the American Medical Association's organizational strategic plan for embedding equity and advancing racial justice and health equity. I'm really especially proud of that. I was a part of that mission when I was with AMA not too long ago, but today, we are really very excited to be joined by Dr. Jamila Michener.

She serves as the associate professor in the department of government at Cornell University, where she's also the co-director of the Cornell Center for Health Equity. She's known as the poverty scholar, right? Yes. I love that about you and your research. Dr. Michener's research focuses on poverty, racial inequality and public policy here in the United States. Her recent book, Fragmented Democracy: Medicaid, Federalism and Unequal Politics, examines how Medicaid in particular affects democratic scholarship and democratic citizenship. Dr. Michener, thank you so much for joining us.

Dr. Michener: Thank you for having me. Hi, everyone.

Keeys: We also have with us on the screenI can't see her heresomeone who I say is probably one of our most compelling voices and eloquent champions of all things related to justice, of really this century, Dr. Ruha Benjamin. Dr. Benjamin is the author of Race After Technology, and I'd be remiss if I didn't show you my dog-eared copy, right? You probably have the same thing on your shelf, right?

Dr. Michener: I love it, yep.

Keeys: Exactly. And she also has a forthcoming book, which I have to make sure to get. It's called Viral Justice: How we Grow the World We Want. She is a professor of African American studies at Princeton University, where she studies the social dimensions of science, medicine, technology, with a focus on the relationship between innovation and inequity, knowledge and power, race and citizenship, and health and justice. She's also a yogi and a recent beekeeper if I'm not mistaken.

Yeah. Thank you so very much, Dr. Benjamin, for joining us today and we really appreciate both of you being here. I'm going to go ahead and jump right into our questions. The first one is for you, Dr. Benjamin. The primary focus of your work is the relationship, as I mentioned before, between innovation and equity, particularly focusing on intersection of race, justice, and technology. Can you speak to the damage that's caused by structural racism in particular and especially the role of exclusionary practices within the field of innovation? Then I'm also wondering how do you feel in terms of hope for restoration?

Dr. Benjamin: Thank you for that question. I'm thrilled to be with you all virtually and so that's a heavy question. I call that a dissertation-worthy question because we could talk about it for hours but I'm going to limit my reflections to a couple of minutes. I think for starters, we have to understand that innovation doesn't necessarily lead to something that is good or desirable. As a starting point for this conversation, we have to disentangle what we think of as technological prowess from social progress, one that doesn't necessarily lead to the other. We can think of many examples. I'll just put a few on the table.

The first person who put up a "Whites Only" sign on their business was being innovative. They were doing something new to get to a certain end. Well, think specifically in terms of historical context. J. Marion Sims, who's sometimes referred to as the father of gynecology, who honed medical techniques by experimenting on enslaved Black women, he was being innovative. Likewise, something like the electric chair, at the time that it was developed, was considered a technological marvel, a more humane way of killing people but we have to ask ourselves, who was that making feel better, that more humane way of killing? Certainly not the person who was on the other end of that innovation.

As a starting point for this conversation, I want to encourage us not to conflate technological prowess with social progress. We should assume that any new invention is going to include social inequities unless and until proven otherwise. That is it is on the onus of those who are creating these new technologies to show us that they are not going to reinforce social inequity and injustice. We can't just go according to the marketing hype because there are all kind of buzzwords that create a shiny veneer of new technologies that hide the actual impact of these.

I'll just name two quick ones in the context of this pandemic and health technologies. Research has shown that the pulse ox that measures oxygen saturation level and many people have used it at home in order to decide when to rush to the hospital. It doesn't work as well on people with darker skin tones. Likewise, there are health care decision algorithms that are currently impacting millions of patients in this country that have shown to have a bias against Black patients even though the algorithms are seemingly color blind. The key here is to understand that glossy exteriors routinely hide dangerous interiors. They don't have to. It's not inevitable but it's predictable.

To this last part of your question, any hope for restoration, yes. But this hope isn't going to come in the form of glossy PR announcements and flashy, eventful initiatives that gather a lot of attention and credit for those who are finally doing something about these issues. Any way forward is not going to be for people but with people who are impacted by harmful systems. It's not going to be top-down but community-driven forms of redress. And also it's not going to make us feel warm and fuzzy if it's really reckoning with the forms of injustice, the complicity.

Here I'm thinking specifically about medical injustice but we can talk about economic injustice. We can talk about housing injustice, so it's not going to feel warm and fuzzy. If it is, then we're probably not doing it right. Finally, I want to say that the harms that are created, that we're talking about, they're created because of business as usual. That means that repair has to happen in everyday practices, in the nitty gritty, in the fine print, in the design of products, and so that's where we should focus our attention rather than on these big flashy forms of restitution that often are just rhetorical rather than substantive.

Keeys: Thank you so very much with that, Dr. Benjamin. I want to just hearken back to some of your words you said. Tech prowess is not equivalent of social progress and innovation is not always for the social good, and then finally you said reckoning is not warm and fuzzy. I'm surmising but I think that that really brings us, segues very well into something I'd like to talk with you about, Dr. Michener. You know, in your research and your writings you describe the application of a racial equity and policy framework. You call it the REAP framework, right? In terms of health policy being innovation, what does that form of innovation offer in terms of advancing restorative justice or that reckoning as Dr. Benjamin mentioned, particularly when it comes to those lasting harms related to unequal health care?

Dr. Michener: Yeah. Thank you for the great question and it's always unfortunate to go after Dr. Benjamin.

Keeys: No, no.

Dr. Michener: Because so much of the kind of core of the framework that I developed that you mentioned is actually reflected in those comments. Two core aspects of that that I'll point out, in particular, that will help me to sort of get to your question around health policy and what health policy has to offer around innovation and restoration, restorative justice. Two core aspects of that framework are as follows. One is that if we want to identify the kind of sources of things like structural racism, these injustices that embed in fundamental ways inequities in our society and in our practices, if we want to be able to identify those so that we can rectify them, we have to attend to the kind of nitty-gritty of process.

Process is more important in many ways than outcome. When it comes to racial disparities, for example, we tend to focus pretty heavily on outcomes. In fact, that's what disparities are. They're an outcome, and of course, there's good reason. Outcomes can flag problems for us but those problems are fundamentally in the process, so part of what I do in the framework is say what parts of the policy process do we need to attend to and where in those various parts of the policy process do opportunities for injustice, for structural racism to be perpetuated, where do those opportunities emerge?

There's a lot there, so I won't say anymore except to say process is crucial and attentiveness to it is crucial. The second partand this is part and parcel of the firstthat's a core aspect of the framework is to say that voice is crucial. In other words, for the folks who have power, who are making decisions, who are making policy at a national level, at a state level, at a local level, sometimes even at the level of specific institutions, businessesfor example, if those folks who have the decision making power and who often have other kinds of power and resources, economic power and so on and so forth, are the primary voices driving policies, those policies will inevitably disadvantage the folks who don't have power.

Whether intentional or not. Good intentions don't actually circumvent that core problem. We have to pay attention to process and a fundamental element that we have to build into process is voice. When it comes to health policy we see this in so many ways. I have a big study that I'm doing right now, a cross-state study, and we're talking to people who have struggled with health problems throughout the pandemic and getting a sense of the kind of nitty-gritty of their experiences and trying to understand what it looks like to create changes in those people's lives on a structural level.

We're working with and advising state and local governments around how they can make policy change to improve the lives of especially people who are at the economic and racial margins. What we're finding is that many of the kinds of innovations that we can get most excited about are experienced really differently in people's everyday lives. We talk to people about things like telehealth, which in many ways can be a great option for folks who have challenges around mobility or disability, for folks who have other kinds of challenges that make it hard for them to get traditional health care but for many other people and even for some of those folks, telehealth as it's actually implemented becomes a potential purveyor of bias and discrimination.

There are lots of examples of that, of things like that. For example, government agencies are constantly adapting new systems. They have these systems for managing their files and managing their clients, and managing their casesand they get pitches from whichever businesses are designing those systems and want to sell them to a government contract, want a government contract that can be very lucrative for them. They get these pitches, and they implement these systems and often have no idea what the consequences are for the people who are relying on the functioning of those systems in order for them to get vital resources for daily lives. Without robust incorporation of the voices and perspectives of those people, without, in fact, them having some power over the processes of innovation, the outcomes will inevitably lead to inequity. That's a lot of the kind of thing that the framework highlights.

Keeys: In your framework it's voice, right? It's voice, it's decentralization and you have to look up her framework, for sure.

Dr. Michener: It's a lot. I was sparing you all of the boring details and trying to draw out the highlights.

Keeys: My takeaway from your framework is that it's not as if legislators or persons in decision power can say we legislate that all people treat their neighbor with kindness and respect. That's not what you're going to see in a law, right? That gets back at the whole idea of good intentions don't necessarily always come through in the process. We're talking here about the process, and the process is not just something that happens in the middle. Restorative justice and bringing in those voices doesn't just happen as a checkpoint. It's continuously across the continuum of the process you referred to.

Dr. Benjamin, I want to bring you back in this conversation here. In your works, you've contributed a lot to a body of work that debates how science and technology shape the social world, in general, and how people can and should and do critically engage techno-science, grappling all the while with the fact that we might bring health and longevity to some, as in those innovative technologies might bring health and longevity to someand to Dr. Michener's pointreally very much leave others by the wayside. Can you speak to those shifts or changes that would likely occur if restorative justice were front and center or even mandatory for leaders and decision-makers within innovation?

Dr. Benjamin: Yeah, I want to talk about this not so much in generalities but I want to offer a very concrete example of this in action that people can study, learn from, adapt to their own context. Very recently two physician researchers at Brigham and Women's Hospital in Boston, they analyzed 10 years of hospital data at Brigham and Women's, specifically among cardiology patients. They found significant disparities in how Black and Latinx patients on the one hand and their white counterparts on the other were being treated when they came to the hospital with heart failure. Black and Latinx patients were sent to general medicine service while white patients were referred to the specialty cardiology service where patients have much better outcomes.

They analyzed this data and then they created what they call the Healing ARCA-R-Cand ARC stands for acknowledge, redress and closure. This team, what they did was they presented this data to the priority neighborhoods around Brigham and Women's, those in which these patients were coming from and they're developing a community oversight initiative specifically around this issue. One of the concrete innovations that their team created was in the electronic medical recordnow you have a flag so that when a provider is looking at a patient's chart, for a Black and Latinx heart failure patient, it flags the provider to refer them to cardiology rather than leaving it to the discretion of the provider or relying on patient's self-advocacy.

The lesson here that Morse and Wispelwey, who are the two physicians leading this research, the lesson here is that not only do they call for society-wide restitution, kind of federal level laws and policies but they are encouraging every single institution and organization to look at the history of racism and inequity in their own locale. What's happening under our own roofs? What forms of disparities are being produced because of business as usual? It doesn't rely on the malice or the hate in someone's heart but it's a combination of a lot of factors that they identified that was leading to these disparities.

What they encourage us to do is to engage in local anti-racist efforts, and in this case, it's a combination of what we might call social innovation that is letting communities lead the process, including them in the research, having their oversight. Remember, community-driven, not top-down, but it also includes a technological component. That is including this flagging function in the electronic medical record that forces providers to reckon with their own bias, not letting them sort of rest on their own assumptions. The last resource I'll just put on the table in addition to Professor Michener's important framework is something everyone can look up called Beyond the Statement, by Color of Change.

Statement there is referring to all of those anti-racist statements that have come out in the last two years in which corporations and organizations and universities lay claim to a certain set of values and commitments. Beyond the Statement is getting us to think about concrete actions, taking those statements and actually directing them into the business as usual. Two things stand out when you look up the Beyond the Statement recommendations. One is incorporating racial equity audits.

That is evaluating the products, the policies, the data that we are producing for discrimination and the other thing, there's a number of recommendations but the other thing I'm just going to highlight for sake of time is that we have to create civil rights-oriented accountability systems that are tied to performance evaluations for employees. That is, what we're talking about here can't be extra icing, only those who self-select into DEI work. It has to be tied to performance evaluations and it has to be civil rights oriented. I would encourage everyone to download and study Beyond the Statement by Color of Change, to really think about how they can implement those recommendations in their own businesses and organizations.

Keeys: I think we had a couple of snaps in the audience with everything you all are saying. We're coming close to time but I just want to give you one last question here, Dr. Michener. With all that you both have identified, what are your overall thoughts in designing practices and policies for monitoring, for building access, for building in accountability at the civil rights level, at the local level with respect to your work?

Dr. Michener: Yeah. You know, again, Dr. Benjamin offered some really, I think, important concrete illustrations and a great resource that she pointed to. I mean, given time to wrap us up, I would emphasize two things and the first, I think, is I always want to say this to people. There are no easy answers and so this is a long game. It's not a game but it's a long process and I can't tell you how many studentsI teach lots of students at Cornelland we will look at policies that were intended to be, whether they were using the language at the time, anti-racist, that were implemented in the 1990s or the early 2000s or the 1960s. We've been trying to do this for so long. Maybe these problems are intractable. Maybe these people, maybe there's something wrong with them and not the systems because we've been trying. We've been doing all of these things.

Certainly, in the wake of George Floyd's murder, there were a whole flurry of policies that were implemented or practices that were implemented, statements that were made across all levels of government, in the business world and beyond, and some of these things are going to come to fruition and perhaps there will be progress clear. Some of them we won't know because no one's measuring or evaluating them, so that's one concrete point. We have to pay attention to the outcomes connected to what it is, the changes that we're making. But some of them are going to fall flat.

They're just not going to work and the temptation is to say, Well, we tried. But the problems are entrenched enough that the focus has to be on long-term solutions and long-term mapping out the processes that work, holding onto the things that show promise, letting go of the things that don't, learning lessons along the way. I want to emphasize that this isn't like, I'm going to think of the cool next DEI thing that's going to fix everything. Just like policy, processes don't unfold like that in government. They don't unfold like that anywhere, so the question is how are we going to deal with mistakes? How are we going to understand what success looks like?

I would emphasize that the voice component is crucial in both of them. Dealing with mistakes, in fact, is a question about restoration and restorative justice. Wow, we didn't mean to do this. We haven't meant to do this but we keep finding ways that we're perpetuating inequities. We can try to ignore it. We can sweep it under the rug. We can deny it. We can point out the things we're doing right so that we can draw attention away from the harms or we can actually focus on restoration and change, and we can get there and can identify and rectify the harms only if we pay attention to the folks who have the most at stake and we ensure that they have power in the processes that are unfolding. The last thing that I would say is that none of this is comfortable. Part of what I always tell people is that power isn't a zero-sum thing. It's not exactly as if the more power I have, the less Mia has but power dynamics do change environments.

If the people who are most affected by things like structural racism, folks at the economic and racial margins, have more power and if we build our practices and our processes to ensure that, it means that the folks who have power now who are comfortable, who are at the top, who are getting to determine what innovation looks like and what the important outcomes are and what success isthose people will have to now share power with others who before didn't have it. Maybe that's some of you, many of you in this room. It's uncomfortable and so recognizing that change that leads us towards restorative justice, social justice, however it is that you frame what the goal is with respect to justice, is uncomfortable and often means sacrifice, and doesn't feel good. I think that's a really important aspect of the commitment.

Keeys: The process of restorative justice. That's it. That's it. Thank you. Dr. Jamila Michener, thank you so very much for your work. Dr. Ruha Benjamin, on a personal level, I studied both of your works for my own dissertation and then also I'll say just by serendipityDr. Ruha Benjamin is a good friend of my late sister and I think if she were here in the flesh, she would be so very proud. So, thank you so much for your attention. Please make sure that you read these ladies' works and apply, apply, apply restorative justice in your own processes through your strategies and thank you so much for your attention.

Disclaimer:The viewpoints expressed in this video are those of the participants and/or do not necessarily reflect the views and policies of the AMA.

View post:
Prioritizing Equity Spotlight series: Centering restorative justice in health innovation - American Medical Association

Array of health threats to Native Hawaiians focus of $22.5M grant | University of Hawaii System News – University of Hawaii

The John A. Burns School of Medicine

Hawaii has the highest life expectancy at birth, according to the Centers for Disease Control and Prevention. Still, that success is not reflected in Native Hawaiian and other Pacific Islander (NHOPI) populations. State data show NHOPI have seven to 10 years less in life expectancy than other Hawaii residents, and researchers from the University of Hawaii at Mnoa John A. Burns School of Medicine (JABSOM) and other UH health sciences units are investigating the sources of the disparities and ways to close the gap.

The National Institutes of Health (NIH) awarded Ola HAWAII researchers a five-year, $22,557,840-million U54 grant to foster research into health disparities and to conduct three large studies to explore genetic, environmental and socio-economic related disparities in health and health-care access for specific communities in Hawaii. Specifically, the studies focus on the long-term impact of COVID-19, the role of exercise with type 2 diabetes and dietary impacts on the Native Hawaiian population.

JABSOM Dean Jerris Hedges and Thompson School of Social Work & Public Health Dean Emeritus Noreen Mokuau serve as multiple principal investigators for Ola HAWAII.

Hedges said, This grant helps unite UH and community members seeking to improve health in Hawaii through sound science.

Funding from the NIH is the premiere form of health research funding because everything you do for NIH connects back to the larger, national agenda on public health and healthcare, said Mokuau.

Based at JABSOM, Ola HAWAII (Ola means health or to heal in Hawaiian, and HAWAII stands for Health And Wellness Achieved by Impacting Inequalities) collaborates with community and UH Mnoa partners. Ola HAWAII investigators seek to close the health and longevity gap between NHOPI and the rest of Hawaiis population through biomedical, behavioral and clinical research.

Its about seeding ideas that best benefit the people of Hawaii, in areas such as cardiovascular health, diabetes and COVID-19, Mokuau added. The John A. Burns School of Medicine is the essential leader in the state of Hawaii for health, in general, and in reducing health care disparities in particular. Ola HAWAIIs work focuses on the kinds of research that help us find new interventions and treatments to support underserved populations who sometimes have less direct access to health care.

As we conduct research that will lead to interventions which help people, at some point, we begin to extend and enhance lives. Thats what this is about.

The three projects part of the grant include:

Exercise, Exosomes & Metabolic Health in Type-2 Diabetes

Native Hawaiians and other Pacific Islanders are disproportionately affected by type 2 diabetes. While exercise can successfully reduce the risk of developing type 2 diabetes, the exercise benefits for the NHOPI population are not as significant when compared to Whites. This study will investigate the role that nano-sized sacs play in lowering the risk of diabetes while identifying exercise and lifestyle guidelines that could be tailored for the NHOPI population. Noemi Polgar, Nicholas James and Scott Ferguson are the principal investigators.

MALAMA: Backyard Aquaponics to Promote Healthy Eating & Reduce Cardiometabolic Risk

Native Hawaiians have the highest mortality rates of cardiometabolic diseases, like heart disease and diabetes. Researchers are testing the efficacy of MALAMA, a culturally-grounded, family-centered backyard aquaponics program thats planted in multiple Native Hawaiian communities. The goal is to reduce food insecurity, while increasing the consumption of healthy foods, which could lower the risk of cardiometabolic diseases in the Native Hawaiian population. Jane Chung-Do and Heidi Ilima Ho-Lastimosa are the principal investigators.

Factors Responsible for the Development of Post-Acute Sequelae of Acute COVID Infection in Hawaii

Nearly a third of people who recover from acute COVID-19 will have whats known as long-COVID. Many of those with long-COVID also have pulmonary problems like persistent cough and labored breathing. Researchers are investigating the change in the bodys function that causes disease, and how social and psychological situations could contribute to long-term outcomes, particularly for Native Hawaiians and other Pacific Islanders and Filipinos. Gehan Devendra and Juwon Park are the principal investigators.

For more information, go to JABSOMs website.

See original here:
Array of health threats to Native Hawaiians focus of $22.5M grant | University of Hawaii System News - University of Hawaii

Turn back the clock with collaborative care solutions Peace Arch News – Peace Arch News

With our ever-increasing levels of stress, lack of sleep, poor diet and pollutants in our environment, our bodies are experiencing increasing strain.

The good news is that by bringing together traditional medicine and groundbreaking wellness therapies through programs such as biohacking, health weight management, hormone balancing and skin rejuvenation, it is possible to address the effects of age-related issues.

These various stressors can increase overall levels of stress hormones like cortisol, says Dr. Jean Paul Lim, from Ageless Living, with locations in Langley, Victoria and coming soon to Kelowna. This has a negative impact on the body by suppressing certain functions required for optimum health and wellness and can lead to weight gain, acne, inflammation, decreased sexual function, low energy, brain fog and a variety of diseases.

One of the various Biohacking treatments at Ageless Living is their hyperbaric oxygen chamber.

What is Biohacking?

The term biohacking refers to making small incremental changes that can have big effects on the bodys ability to optimally perform, Dr. Lim explores, pointing to tools such as their infrared sauna, hyperbaric oxygen chamber, pulsed electromagnetic field therapy and other therapies designed to encourage rejuvenation and increase performance.

What is Hormone Balancing?

Unlike earlier therapies like Hormone Replacement Therapy (HRT) that used animal hormones, our hormone balancing treatments use bio-identical hormone restoration, Dr. Lim says. This means they look chemically identical to our own natural hormones, and besides helping to boost our natural levels, may help reduce the risk of some chronic health conditions.

With physicians board-certified in anti-aging and regenerative medicine, Ageless Livings MD-directed hormone balancing and health weight programs can help both men and women of all ages achieve optimal health and function.

The team of professionals offer traditional medicine and groundbreaking wellness therapies as a collaborative care solution.

Initial consultation what to expect

Your Ageless Living physician will review your medical history and hormone cascade, and run some tests which may include serum, saliva and/or urine. You may also have a nutritionist do a full nutritional history review, review test results with your physician, and then theyll create your treatment plan.

The goal is not only to increase longevity, but also quality of life, allowing you to live your life to the fullest, Dr. Lim says.

Other clinics offer just aesthetics or hormone balancing, he says. We stand apart because we offer team-based, integrated solutions that bring all these tools and technologies together as a collaborative care solution.

Find out more on Facebook and Instagram, or book a treatment online.

Health and wellness

Continued here:
Turn back the clock with collaborative care solutions Peace Arch News - Peace Arch News

QC Kinetix (Freeport) is a Premier Sports Medicine Clinic, Improving the Performance of Athletes – Yahoo Finance

Freeport, ME - (NewMediaWire) - September 19, 2022 - via QC Kinetix - Sports medicine physicians have special training to restore movement/function to injured patients, allowing them to get back into the field or gym. While they work with professional or amateur athletes, they treat children/teens involved in sports, personal fitness enthusiasts, adults who love outdoor activities, and workers with physically demanding jobs. At QC Kinetix (Freeport), a team of medical providers treats physical conditions, dislocations, fractures, strains, sprains, and other sports injuries. They use advanced diagnostic equipment, medical technology, and techniques to discover and treat the root cause of pain.

To further its mission of improving the quality of life of athletes, QC Kinetix partnered with the NFL's all-time leading rusher and Dancing with the Stars Champion, Emmitt Smith. Between injuries on the field and the wear/tear on his joints dancing his way to a Mirror Ball Trophy, Mr. Smith prioritized taking care of his body. He credits the longevity of his joints to the regenerative therapies offered at the clinic.

"QC Kinetix provides several therapies and advanced treatments which complement and promote the body's natural healing process. It's always exciting to partner with a company when you've experienced first-hand the quality and effectiveness of their products." Emmitt Smith.

Minor and severe sports injuries that affect the tendons and ligaments take several weeks/months to heal, even with extensive rest. Traditional sports physicians recommend ice, elevation, compression, physical therapy, or medication to see an athlete through an injury. However, the regenerative medicine clinic offers a reliable and effective way of treating sports injuries. Their protocols are minimally invasive and aim to trigger the healing/repair of damaged tissue. In sports medicine, regenerative therapies speed up what the body naturally does by taking advantage of its healing capabilities.

The regenerative medicine protocols at QC Kinetix (Freeport) work best as part of a recovery routine that includes extended rest and bracing. By combining alternative therapies with traditional sports treatments, patients recover faster and experience improved performance/mobility. Sports medicine therapies restore degenerated tissues for athletes with a torn rotator cuff, torn Achilles tendon, shoulder pain, wrist pain, tennis elbow, golfer's elbow, low back pain, and ligament tears.

Athletes who've had trouble walking or performing activities can visit the clinic for natural knee pain treatments. The providers eliminate the need for total knee replacement surgery, where surgeons replace damaged cartilage and bone with metal implants and a plastic spacer. With regenerative therapies, patients can recover from chronic knee pain, bone-on-bone osteoarthritis, decreased range of motion, torn meniscus, and torn ACL/MCL without steroids, arthroscopic surgery, or physical therapy. Natural knee treatments reduce pain with fewer side effects and minimal recovery time.

Alongside sports injury treatments, QC Kinetix (Freeport) treats patients with non-sports-related musculoskeletal pain resulting from poor body mechanics, muscle overuse, repetitive/jerking movements, and physical trauma. Regenerative medicine is well known for joint pain relief and treatment of soft tissue injuries as they rely on stimulating the body's natural healing response. It's also an aggressive, minimally invasive alternative to anti-inflammatories, painkillers, physical therapy, and therapeutic massages. Besides helping patients avoid complicated and costly surgical procedures, regenerative therapies are an option where other traditional orthopedic treatments have failed to offer relief.

On a patient's first visit, the providers conduct extensive consultations to understand their conditions and overall health goals before determining and diagnosing the root cause of joint pain/musculoskeletal injuries. Once completed, they educate the patient about the therapies they offer and the most appropriate treatment methods to improve pain, decrease inflammation, or repair degenerated tissues.

"Our mission is to help as many patients as possible enjoy a higher quality of life by improving their musculoskeletal pain and injuries with natural treatment options, thereby prolonging or eliminating the need for surgical intervention." Company Representative.

The patient experience at QC Kinetix (Freeport) is unmatched in the medical field as the team provides concierge-level service, compassionate care, and mutual respect. Their approach to treatment has earned the clinic many 5-star reviews, positive testimonials, and long-term relationships with the local communities. Learn more about their Freeport office by visiting their website or calling (207) 800-1452. The clinic is located at 23 Durham Rd, Suite 301, Freeport, ME, 04032, US.

Media Contact:

Company Name: QC Kinetix (Freeport)

Contact Person: Scott Hoots

Phone: (207) 800-1452

Address: 23 Durham Rd, Suite 301

City: Freeport

State: ME

Postal Code: 04032

Country: US

Website: https://qckinetix.com/portland-me/freeport/

More:
QC Kinetix (Freeport) is a Premier Sports Medicine Clinic, Improving the Performance of Athletes - Yahoo Finance

Sheba to launch worlds first dedicated longevity clinic – The Jerusalem Post

As most people want to live longer and with good health, Sheba Medical Center at Tel Hashomer will open in September on its campus the worlds first public hospital longevity center to provide advanced, research-based medicine for maintaining and improving peoples physiological and mental functions.

The Sheba Longevity Center is being planned to promote longer, healthier lives, built on multidisciplinary fields of healthcare and technology.

It will first focus on a pilot study and treatment for some 2,000 patients aged 40 and over in the fields of cognition, sleep, frailty and menopause before branching out to other fields. This effort will pioneer a new type of patient care.

Longevity is an international issue that requires global cooperation, said Prof. Tzipi Strauss, the founder and creator of the center. Today, Sheba has brought together players from across the globe to share knowledge, collaborate and raise awareness of the possibilities this field brings. Through this new annual conference and our clinic, we hope to continue our mission of democratizing the field of longevity, making it accessible to all.

The Sheba Longevity Conference, held this week, united global longevity stakeholders to discuss advances and breakthroughs in medicine for healthier, longer lives. The event featured discussions on how multidisciplinary fields of healthcare, including genomic testing, dieting, stem cell aging and artificial intelligence (AI), could be applied to longevity practice. Attendees included leading researchers from the US, Europe, Africa, the Gulf region and East Asia alongside senior Israeli government officials and health tech leaders.

The Sheba center will build on the existing strong foundations of the hospital, and benefit from its multidisciplinary experts, said internal medicine Prof. Evelyne Bischof at the Shanghai University of Medicine and Health Sciences who will be the director and manage day-to-day operations. Built on a base of clinical evidence, using AI and the latest cutting-edge health tech, the Sheba Longevity Center will combine the best elements of modern-day medical care. Based in Sheba, the city of health, our partnerships across the world will help us achieve a truly global impact.

The Longevity Center will collaborate closely with Shebas innovation arm, ARC (Accelerate, Redesign, Collaborate) to promote innovation in the field and incubate start-ups that will contribute to longer, healthier lives. The center will also establish an educational hub working closely with academic institutes, longevity associations and regulatory bodies to build the next generation of longevity scientists.

In 10 years time, due to changing demographics and rising costs, we will not be able to provide the same level of care that we are providing today; we need transformation to continue providing quality care, added Prof. Yitshak Kreiss, the director-general of Sheba, Israels largest hospital. The approach being pioneered by Prof. Strauss will see a shift from treating diseases to promoting health, building towards longer, healthier aging within a center that will provide world-leading, clinically backed, integrative medicine.

Read more from the original source:
Sheba to launch worlds first dedicated longevity clinic - The Jerusalem Post

Cognition declines with age, but mental well-being may increase – The Hill

Story at a glance

While its generally known cognitive function declines with age, new research suggests mental well-being may increase as people grow older.

A study published in Psychology and Aging found healthy older adults displayed greater mental well-being but worse cognitive performance than younger adults. Researchers from the University of California San Diego School of Medicine sampled a total of 62 healthy younger adults in their 20s and 54 healthy older adults over the age of 60.

Participants were surveyed on symptoms of anxiety, depression, loneliness and overall mental well-being and were also tasked with performing a series of cognitively demanding tasks while their brain activity was measured using electroencephalography (EEG).

Results showed young adults experienced higher rates of anxiety, depression and loneliness compared to adults over the age of 60. Older adults showed higher levels of well-being but did worse in performing the cognition tests.

According to the study, EEG recordings among older adults showed greater activity in the anterior parts of the brains default mode network during cognition tests. This part of the brain is more active during passive tasks, such as thinking about the future and daydreaming, and is typically suppressed during tasks demanding focused external attention.

The default mode network is useful in other contexts, helping us process the past and imagine the future, but its distracting when youre trying to focus on the present to tackle a demanding task with speed and accuracy, Jyoti Mishra, senior author of the study and associate professor of psychiatry at UC San Diego School of Medicine, said in a statement.

Meanwhile, high cognitive scores among young participants were associated with greater activity in part of the brains executive control system, the dorsolateral prefrontal cortex. But among older adults, those with higher cognitive performances showed increased activity in an area of the brain associated with attention and avoiding distractions, the inferior frontal cortex. Researchers note the dorsolateral prefrontal cortex degrades with aging, suggesting the inferior frontal cortex may pick up the slack for older adults when concentrating on a task.

We tend to think of people in their twenties as being at their peak cognitive performance, but it is also a very stressful time in their lives, so when it comes to mental well-being, there may be lessons to be learned from older adults and their brains, Mishra added.

The rest is here:
Cognition declines with age, but mental well-being may increase - The Hill

Alzheimer’s disease: Stress may increase risk in females – Medical News Today

Alzheimers disease is the most common form of dementia, causing up to 70% of dementia cases. According to the Alzheimers Association, it affects some 6 million people in the United States, and around two-thirds of those affected are women.

Increasing age is the greatest risk factor for Alzheimers disease, and women, on average, live longer than men. According to the Centers for Disease Control and Prevention (CDC), in 2021, womens life expectancy at birth in the United States was 79.1 years, compared with 73.2 for men.

Dr. Emer MacSweeney, CEO and consultant neuroradiologist at Re:Cognition Health, told Medical News Today that the risk of developing Alzheimers disease is multifactorial, with a higher incidence in women than men, even when adjusted for the longer average life span for women.

Those extra life years alone cannot fully explain the difference in Alzheimers disease risk between women and men. Recent research has suggested that hormonal changes after menopause may contribute to risk.

And women may have a greater genetic risk, too the APOE e4 gene variant, which increases dementia risk and is carried by around 15% to 25% of people, seems to have more effect in women than men.

Also under investigation are societal and lifestyle factors. The Alzheimers Association recently reported that women who undertook paid employment had slower memory decline in late life than those who did not.

Recent research has focused on whether stress is a contributing factor. It has been shown that stress can accelerate symptoms of Alzheimers, but how might it increase the risk of developing Alzheimers disease?

A new study has found that stress leads to a rise in beta-amyloid in female mice, and not in males. Beta-amyloid forms plaques in the brain that interfere with nerve impulses and trigger inflammation and are widely thought to be responsible for many of the symptoms of Alzheimers disease.

The study, from Washington University School of Medicine, St. Louis, is published in Brain.

Stress can have a profound effect on the body and we are understanding more about the implications it can have to our mental and physical health both positive and negative, explained Sebnem Unluisler, genetic engineer and chief longevity officer at the London Regenerative Institute in the United Kingdom, not involved in the study.

Stress triggers the release of hormones such as cortisol and adrenaline, which, if produced excessively or over a prolonged period of time, can have a hugely negative effect on the body, causing inflammation, damage to DNA and cells, and accelerating the aging process, which of course can affect the brain and cognition, she added.

Dr. John Cirrito, co-lead study author, and a professor in the Department of Neurology at Washington University School of Medicine in St. Louis, also told us why stress might play a role in Alzheimers risk in women:

Many other studies have demonstrated that women are more likely to be stressed, that stress is linked to increased risk of Alzheimers disease, and that women are at higher risk of Alzheimers disease. We are not the first to put together this possible link. However, there could many possible reasons that link stress, women and Alzheimers disease, including correlational, comorbidities, and lifestyle.

Our study demonstrates a direct link between stress and Alzheimers disease in women at a cellular level, he told MNT.

Whilst stress has been accepted as a significant risk factor, Edwards et al have provided new data from studies on mice to explain why a different response to stress may account for the higher incidence of Alzheimers disease in women, compared to men, said Dr. MacSweeney.

Using mice, the researchers in the current study investigated the effect of stress on levels of beta-amyloid in the interstitial fluid of the hippocampus. The hippocampus is an area of the brain that is affected in the early stages of Alzheimers disease and continues to deteriorate as the disease progresses.

They exposed mice to one of two stressors restraint stress or olfactory stress for 3 hours.

Restraint stress involved placing the mouse in a small, clear, plastic container with air holes that restricted their movement.

For olfactory stress, a small tube containing 0.1 milliliters (ml) of urine from a predator (fox, bobcat, or coyote) was placed in their normal cage. The urine was swapped every 30 minutes so the mice did not become accustomed to the scent of one predator.

Beta-amyloid levels were measured before, during, and after stress, for a total of 22 hours.

The researchers measured levels of stress hormones in the blood of the mice, and found that males and females were experiencing similar levels of stress. But there was a significant difference in beta-amyloid levels.

In female mice, beta-amyloid levels in the interstitial fluid rose by around 50% within the first 2 hours of stress, and stayed elevated for the rest of the monitoring period. Only about 20% of male mice exhibited a small, delayed increase in beta-amyloid.

Dr. Cirrito explained the importance of raised beta-amyloid in the interstitial fluid: In mice there is a tight correlation between the concentration of [interstitial fluid] beta-amyloid within a brain region and if/ how much that region develops beta-amyloid plaques. Elevated [interstitial fluid] beta-amyloid also drives plaque formation (vice versa with suppressed [interstitial fluid] beta-amyloid).

However, he added that it is difficult to make that direct comparison in humans since we cannot measure [interstitial fluid] as readily in people.

Key to the difference between males and females was the cellular response to the stress hormone, corticotropin-releasing factor (CRF).

In female mice, nerve cells take up this hormone. The cascade of events that follows increases levels of beta-amyloid in the brain. The nerve cells of male mice do not take up the hormone.

The researchers suggest that this is due to the CRF receptor acting differently in males and females.

Whilst the study strongly suggests stress is one potential factor that may influence risk, quite significantly, it is still only one of many factors. However, the authors are the first to determine, at the cell signaling level, why stress differentially affects disease-related proteins in males and females.

Dr. Emer MacSweeney

While this finding in mice is important, the researchers recognize that the mechanism may not be the same in people. However, their findings may help show directions for further research and treatment, as Dr. MacSweeney explained.

It is not possible to extrapolate, with confidence, that this differential response to stress in mice translates precisely to humans, she told us. However, the physiological explanation in mice is interesting, and could provide, at least in part, the explanation for the gender differences between men and women for risk of Alzheimers.

The finding is, in turn, important in guiding future pharmaceutical research towards new treatment options, that may differ between males and females, she added.

Read more:
Alzheimer's disease: Stress may increase risk in females - Medical News Today

The Trippiest Psychological Thriller on Amazon Showcases a … – Inverse

In a post-Roe world, Amazons newest series Dead Ringers is unapologetically visceral and poignantly clinical. A gender-flipped, highly divergent remake of David Cronenbergs 1988 film follows the complicated relationship of Elliot and Beverly Mantle (both played by Rachel Weisz), twin obstetrician-gynecologists whose brilliance tests the equilibrium of their bond, the lens through which the disequilibrium between women and their bodies is explored.

Warning: Spoilers for Dead Ringers below!

Channeling the psychosexual thriller qualities of its cinematic progenitor, Dead Ringers rides its science hard at times. At the Mantles holistic birthing center, where babies and bioethical conundrums are very much thematic twins, uber-wealthy women want to use the Mantles intellect to skirt legal regulations around surrogacy and create bespoke services that promise everlasting youth and longevity.

In particular, Elliot Mantle, the more scientifically driven of the pair, boasts that menopause a natural biological process marking the end of an individuals reproductive years with the permanent cessation of menstruation is as easily malleable as a magician bending a spoon.

We can postpone it. We can delay the onset of it, says Elliot at a dinner meeting with potential investors for the new birthing center in the second episode. Its a good example of something that we technically know how to do, but were limited by law, ethics, finances, bodies to experiment on.

Elliot makes an even bolder claim that menopause could be prevented indefinitely through a real-life procedure called ovarian tissue freezing. Such a technique, the twin insists, would have women preserving their own ovarian tissue when theyre brimming with estrogenic youthfulness and re-implanting on the rainy days of hot flashes and unsexy infirmity.

Its a not-so-subtle dig at the booming anti-aging culture so dependent on making us feel bad for sprouting a crows feet or two. But is it really possible to counter menopause really, reproductive aging with a simple tissue implant? The prospect of that feminine fountain of youth is much closer than you think, although it is questionable whether its even worth it.

Also known as ovarian tissue cryopreservation, its a still-experimental procedure where a portion of an individuals ovarian tissue is surgically removed and then placed into cold storage for fertility preservation and future use, Elizabeth Rubin, an obstetrician-gynecologist and reproductive endocrinology fellow at Oregon Health and Science University, tells Inverse.

Typically, [its done] in situations in which people with ovaries are about to undergo an extremely gonadotoxic therapy, such as certain types of chemotherapy, or are known to have a condition, usually genetic, in which they will go through menopause, either around or even before the time of puberty, she explains.

While there are other routes to preserve future fertility, such as egg or embryo freezing, these arent options for individuals who are too young, cant delay their cancer treatment, or recently had chemotherapy.

The ASRM [American Society for Reproductive Medicine] still considers ovarian tissue cryopreservation or freezing experimental, Michelle Roach, assistant professor of obstetrics and gynecology at Vanderbilt University Medical Center, tells Inverse. Its not something routinely done except at a few centers the best way to preserve fertility, its still egg freezing or oocyte preservation.

The magic is in the anti-freeze solution and technologies, explains Kutluk Oktay, professor of obstetrics and gynecology at the Yale School of Medicine and medical director of Innovation Fertility Preservation and IVF.

You cannot just take the tissue and stick it in your fridge or freezer, Oktay tells Inverse. He says that when you freeze a cell this way, ice crystals form and damage the delicate components of the cell. Instead, you prepare very thin slices [of ovarian tissue] that fit into test tubes fitted to specialized machines, and then you mix them with cryoprotectants.

Once locked away like Han Solo in carbonite according to a specific freezing formula, these slices of mostly the ovarian cortex the outer layer of the ovary containing primordial follicles (aka immature eggs) are kept under watchful eyes for several years in specially equipped storage facilities.

When someone is ready to use their iced eggs for pregnancy, the tissue is thawed and then placed back into the body near any remaining ovarian tissue or where it was initially removed. It may also be placed, as suggested by Dead Ringers Elliot Mantle, in the armpit, which is nicely vascularized and rich in blood, but more on that later.

According to Memorial Sloan Kettering Cancer Center, around 200 babies worldwide have so far been born from preserved ovarian tissue, with half of those pregnancies occurring naturally and the other half with help from assisted reproductive technology techniques like in vitro fertilization (or IVF).

In his clinic, Oktay who performed the first reported ovarian tissue autotransplantation (going back into the tissue donor versus someone else) in 1999 says hes seen it work for patients in whom ovarian tissue was harvested when they were teenagers, a decade and one ovarian tissue transplant later were able to have two or three children, either naturally or through IVF.

But as with anything in science, theres always a catch. One impediment to the success of ovarian tissue cryopreservation is that when the tissue is reimplanted, the number of eggs you start with isnt the number of eggs you end with. This is crucial because every individual with ovaries, for the most part, is born with a set number of eggs that slowly dwindle with age.

The one hurdle we have, which were overcoming with time, is that freezing and thawing doesnt kill that many eggs, says Oktay. But when you transplant, theres an ischemic stage by the time the blood vessels are formed, according to animal models, you could lose 60 percent of all the eggs [in the transplanted tissue].

Oktay and his colleagues at Yale are investigating pharmacological ways to stave off primordial follicle death We predict we can reduce those losses to about 20 percent, he says. But even before that, theres the risk this fertility preservation could, ironically, trigger menopause, which brings us to the much-anticipated answer.

When we jump to episode three, Elliot performs ovarian tissue freezing on a young 24-year-old woman named Stacy to a live audience watching behind a glass window amid the dark lighting and eerie red surgical gowns.

When Stacy is on the precipice of the menopause, her frozen ovarian tissue will be thawed out and grafted back into her body thus restoring her declining sex hormones and delaying the menopause for potentially 20 years, says Elliot in the show.

For women experiencing symptoms associated with the transition to menopause, there are hormonal and non-hormonal therapies available.

Oktay says in his own clinic, hes definitely seen ovarian tissue transplantation (OTT) stall menopause in some individuals, but never as long as 20 years. In one small 2020 study where about four healthy menopausal women around 47 years old had their banked ovarian tissue successfully grafted back, the tissue was functional for at least six months.

Theres also a possibility that ovarian tissue freezing can trigger early menopause, rendering efforts to safeguard future reproductive health kind of futile and impractical.

For example, if you were under 18 and we took a whole ovary, you may experience early menopause earlier by seven years, based on some studies looking at people who had their ovaries removed for medical reasons, says Oktay. But as you get older, that number is less and less.

For example, shooting for ovarian tissue freezing between ages 30 and 40 may harken menopause a year or two earlier than expected. However, you have to balance that with the fact nothing trumps younger eggs when it comes to quality and survivability and, in turn, what will be more effective at keeping menopause at bay for longer when youre older.

Were working with mathematicians, and weve put together molecular and clinical information and mathematical formulas in a model, which would be available to patients to enter their age, the desire [time] of delay, and that will tell them whether [going with ovarian tissue freezing] makes sense for them or how much tissue to take out, says Oktay.

(In the show, the character Elliot mentions the possibility of grafting tissue from one individual to another unrelated individual. Oktay and Rubin of OHSU say, just like you need matching between donors, you would run into the same challenge with OTT.)

Rubin and Roach of VUMC feel that ovarian tissue freezing as a means to delay menopause is a bit much. Thanks to modern medicine, individuals experiencing this completely natural life transition have many therapies available to help cope with symptoms like hot flashes, low sex drive, or other mood symptoms. These therapies include exogenous hormone replacement with estrogen or progesterone, whats known as hormone replacement therapy, as well as antidepressants and even cognitive behavioral therapy.

Whether the future holds a cure for reproductive aging, the researchers say thats hard to determine. Aging is inevitable, and so too could be our attitude of whole-hearted self-acceptance if we so choose.

See the article here:
The Trippiest Psychological Thriller on Amazon Showcases a ... - Inverse

Artificial intelligence identifies anti-aging drug candidates targeting ‘zombie’ cells – Phys.org

This article has been reviewed according to ScienceX's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

proofread

by Ten Bridge Communications

A new publication in the May issue of Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, demonstrates the power of artificial intelligence (AI) to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.

The paper, "Discovering small-molecule senolytics with deep neural networks," authored in collaboration with researchers from the Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard, describes the AI-guided screening of more than 800,000 compounds to reveal three drug candidates with comparable efficacy and superior medicinal chemistry properties than those of senolytics currently under investigation.

"This research result is a significant milestone for both longevity research and the application of artificial intelligence to drug discovery," said Felix Wong, Ph.D., co-founder of Integrated Biosciences and first author of the publication. "These data demonstrate that we can explore chemical space in silico and emerge with multiple candidate anti-aging compounds that are more likely to succeed in the clinic, compared to even the most promising examples of their kind being studied today."

Senolytics are compounds that selectively induce apoptosis, or programmed cell death, in senescent cells that are no longer dividing. A hallmark of aging, senescent cells have been implicated in a broad spectrum of age-related diseases and conditions including cancer, diabetes, cardiovascular disease, and Alzheimer's disease. Despite promising clinical results, most senolytic compounds identified to date have been hampered by poor bioavailability and adverse side effects. Integrated Biosciences was founded in 2022 to overcome these obstacles, target other neglected hallmarks of aging, and advance anti-aging drug development more generally using artificial intelligence, synthetic biology and other next-generation tools.

"One of the most promising routes to treat age-related diseases is to identify therapeutic interventions that selectively remove these cells from the body similarly to how antibiotics kill bacteria without harming host cells. The compounds we discovered display high selectivity, as well as the favorable medicinal chemistry properties needed to yield a successful drug," said Satotaka Omori, Ph.D., Head of Aging Biology at Integrated Biosciences and joint first author of the publication. "We believe that the compounds discovered using our platform will have improved prospects in clinical trials and will eventually help restore health to aging individuals."

In their new study, Integrated Biosciences researchers trained deep neural networks on experimentally generated data to predict the senolytic activity of any molecule. Using this AI model, they discovered three highly selective and potent senolytic compounds from a chemical space of over 800,000 molecules. All three displayed chemical properties suggestive of high oral bioavailability and were found to have favorable toxicity profiles in hemolysis and genotoxicity tests.

Structural and biochemical analyses indicate that all three compounds bind Bcl-2, a protein that regulates apoptosis and is also a chemotherapy target. Experiments testing one of the compounds in 80-week-old mice, roughly corresponding to 80-year-old humans, found that it cleared senescent cells and reduced expression of senescence-associated genes in the kidneys.

"This work illustrates how AI can be used to bring medicine a step closer to therapies that address aging, one of the fundamental challenges in biology," said James J. Collins, Ph.D., Termeer Professor of Medical Engineering and Science at MIT and founding chair of the Integrated Biosciences Scientific Advisory Board. Dr. Collins, who is senior author on the Nature Aging paper, led the team that discovered the first antibiotic identified by machine learning in 2020.

"Integrated Biosciences is building on the basic research that my academic lab has done for the last decade or so, showing that we can target cellular stress responses using systems and synthetic biology. This experimental tour de force and the stellar platform that produced it make this work stand out in the field of drug discovery and will drive substantial progress in longevity research."

More information: Felix Wong et al, Discovering small-molecule senolytics with deep neural networks, Nature Aging (2023). DOI: 10.1038/s43587-023-00415-z

Journal information: Nature Aging

Provided by Ten Bridge Communications

See the original post here:
Artificial intelligence identifies anti-aging drug candidates targeting 'zombie' cells - Phys.org

Scientists find a protein in bats that can slow aging and fight most … – Earth.com

Could the key to slowing human aging and fighting off ailments like Covid, heart disease, and arthritis be hiding in the wings of bats? A recent study suggests it just might be.

Bats, remarkable creatures that live for around 20 years on average, appear to be unscathed by pathogens that prove deadly to humans, such as Ebola and Covid.

This intriguing fact has prompted scientists to take a closer look at these animals, hoping to uncover the secret behind their resistance to sickness, and see if it can be replicated in humans.

The study, conducted by researchers at Duke-NUS Medical School in Singapore, led to the discovery of a protein that forms the backbone of bats extraordinary immune defense.

The protein, named bat ASC2, showed remarkable promise in genetically engineered mice. The research team is optimistic that it may one day be harnessed to save millions of human lives.

Bat ASC2 is a modified version of a protein that halts the inflammatory response in bats, providing them with their unique resistance to viruses. In a statement, the research team explained, Our results demonstrate an important mechanism by which bats limit excessive virus-induced and stress-related inflammation with implications for their long lifespan.

The scientists tested this proteins effectiveness by genetically modifying mice to carry the ASC2 protein. The results were astonishing. The mice demonstrated the same defensive properties against inflammation as the bats, as reported in the study published in the journal Cell.

Further investigation into why bats excel at fending off viruses revealed more about the ASC2 protein. When tested on human cells, these cells became more resistant to disease, showing the therapeutic potential of bat ASC2.

The protein works by dampening inflammasomes the part of the immune system that drives inflammatory responses when infection strikes.

Dr. Linfa Wang, a professor of emerging infectious diseases at Duke-NUS Medical School, spoke to The Telegraph about the potential of bat ASC2 in contributing to human longevity and reducing mortality from viruses.

He cautioned: It may not be the only factor, as biology is never as simple as one molecule or one pathway. But the overall dampening of inflammation most likely plays a role in health aging in bats.

Dr. Wang further explained that this discovery could lead to the development of new medicines that mimic ASC2, offering a potential treatment for various viruses that trigger an inflammatory response in humans.

We have filed patents based on this work and are exploring commercial partnerships for drug discovery, said Dr. Wang. We are hoping to develop a new class of anti-inflammatory drugs for inflammasome-driven human diseases.

Interestingly, mice carrying the ASC2 adaptation saw their death rate from a deadly flu virus drop dramatically from 100 percent to 50 percent. In addition, the ASC2 protein substantially inhibited the Zika virus in these genetically engineered mice.

Both humans and bats carry the ASC2 protein, but the researchers speculate that it may have evolved to be stronger in bats due to the immense physiological stress that comes with flight.

Bats, the only mammals capable of powered flight, may have developed a means to suppress their inflammatory immune response as a survival mechanism. This theory suggests the metabolically costly flight could be a key driver for this adaptation.

The research findings have sparked interest among experts worldwide. Professor Gilda Tachedjian, head of Life Sciences at the Burnet Institute in Australia, acknowledged the significance of the study. She told The Telegraph: The researchers have proved the concept that bat ASC2 protein can target the part of the immune system responsible for inflammatory responses, and therefore reducing inflammation in cells in a petri dish and in mice.

However, she tempered her praise with caution, adding, While the findings of this study are intriguing, more work is needed to translate these findings into new therapies that can be used in people to reduce mortality from viruses or increase longevity.

Indeed, the road from promising laboratory findings to effective human therapies can be long and arduous. The discovery of bat ASC2s potential is just the beginning. To fully understand how this protein works and to harness its power for human health, extensive further research is necessary.

The current study does, however, underscore the incredible potential that nature holds for medical breakthroughs. As scientists continue to investigate bats remarkable resilience to viruses, they are gaining insights that could transform our approach to human health and longevity.

In the fight against diseases like Covid and conditions such as heart disease and arthritis, bats could prove to be an unexpected ally. Their unique protein could provide a template for new anti-inflammatory drugs that could not only save lives but also extend them.

The quest for longevity and disease resistance has been a long-standing challenge for humanity. Now, it appears that the solution may be soaring in the night sky, in the form of these winged mammals. As we continue to study and learn from them, bats may just hold the key to unlocking a new frontier in human health and medicine.

As we wait for the next steps of this exciting research, its clear that the humble bat, a creature that has inspired myth and legend for centuries, may soon find itself at the center of a scientific revolution. The study of bat ASC2 has the potential to reshape our understanding of disease, immunity, and the very nature of aging. And who knows? The secret to a longer, healthier life may just be a bats flight away.

-

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

More here:
Scientists find a protein in bats that can slow aging and fight most ... - Earth.com

Part-Time Physician: Is It a Viable Career Choice? – Medscape

Despite a push toward work-life balance in the medical field, physicians continue to dedicate more time to work and less time to themselves, their loved ones, and their outside interests. On average, physicians reported in the Medscape Physician Compensation Report 2023 that they worked 50 hours per week. Five specialties, including critical care, cardiology, and general surgery reported working 55 or more hours weekly.

But there's a small segment of physicians that has bucked the norm. They've scaled back their hours to part-time, clocking in only 25-30 hours a week.

In 2011, The New England Journal of Medicine reported that part-time physician careers were rising. At the time, part-time doctors made up 21% of the physician workforce, up from 13% in 2005.

In a more recent survey from the California Health Care Foundation, only 12% of California physicians said they devoted 20-29 hours a week to patient care.

Amy Knoup, a senior recruitment advisor with Provider Solutions & Development (PS&D), has been helping doctors find jobs for over a decade, and she's noticed a trend.

"Not only are more physicians seeking part-time roles than they were 10 years ago, but more large healthcare systems are also offering part-time or per diem as well," says Knoup.

Ten years ago, the fastest growing segment of part-timers were men nearing retirement and early-to-mid-career women.

Pediatricians led the part-time pack in 2002, according to an American Academy of Pediatrics study. At the time, 15% of pediatricians reported their hours as part-time. However, the numbers may have increased over the years. For example, a 2021 study by the Department of Pediatrics, Boston Medical Center, and the School of Medicine, Boston University, found that almost 30% of graduating pediatricians sought part-time work at the end of their training.

At PS&D, Knoup says she has noticed a trend toward part-timers among primary care, behavioral health, and outpatient specialties such as endocrinology. "We're also seeing it with the inpatient side in roles that are more shift-based like hospitalists, radiologists, and critical care and ER doctors," she said.

Another trend Knoup has noticed is with early-career doctors. "They have a different mindset," she said. "Younger generations are acutely aware of burnout. They may have experienced it in residency or during the pandemic. They've had a taste of that and don't want to go down that road again, so they're seeking part-time roles. It's an intentional choice."

Tracey O'Connell, MD, a radiologist, always knew that she wanted to work part-time. "I had a baby as a resident, and I was pregnant with my second child as a fellow," she said. "I was already feeling overwhelmed with medical training and having a family."

O'Connell worked in private practice for 16 years on Mondays, Wednesdays, and Fridays, with no nights or weekends.

"I still found it completely overwhelming," she said. "Even though I had more days not working than working, I felt like the demands of medical life had advanced faster than human beings could adapt, and I still feel that way."

Today she runs a part-time teleradiology practice from home but spends more time on her second career as a life coach. "Most of my clients are physicians looking for more fulfillment and sustainable ways of practicing medicine while maintaining their own identity as human beings, not just the all-consuming identity of doctor,'" she said.

On the other end of the career spectrum is Lois Goodman, MD, an ob/gyn in her late 70s. After 42 years in a group practice,she started her solo practice at 72, seeing patients three days per week. "I'm just happy to be working. That's a tremendous payoff for me. I need to keep working for my mental health."

Reducing clinical effort is one of the strategies physicians use to scale down overload. Still, it's not viable as a long-term solution, says Christine Sinsky, MD, AMA's vice president of professional satisfaction and a nationally regarded researcher on physician burnout.

"If all the physicians in a community went from working 100% FTE clinical to 50% FTE clinical, then the people in that community would have half the access to care that they had," said Sinsky. "There's less capacity in the system to care for patients."

Some could argue, then, that part-time physician work may contribute to physician shortage predictions. An Association of American Medical Colleges report estimates there will be a shortage of 37,800 to 124,000 physicians by 2034.

But physicians working part-time express a contrasting point of view. "I don't believe that part-time workers are responsible for the healthcare shortage but rather, a great solution," says O'Connell. "Because in order to continue working for a long time rather than quitting when the demands exceed human capacity, working part-time is a great compromise to offer a life of more sustainable well-being and longevity as a physician, and still live a wholehearted life."

Rachel Miller, MD, an ob/gyn, agrees. "Instead of quitting and coming up with something else to do, it [working part time] increases my longevity to practice medicine."

Pros and Cons of Being a Part-Time Physician

Pros

Less Burnout: The American Medical Association has tracked burnout rates for 22 years. By the end of 2021, nearly 63% of physicians reported burnout symptoms compared with 38% the year before. Going part-time appears to reduce burnout, suggests a study published in Mayo Clinic Proceedings.

Better Work-Life Balance: Rachel Miller, MD, an ob/gyn, worked 60-70 hours weekly for 9 years. In 2022, she went to work as an OB hospitalist for a healthcare system that welcomes part-time clinicians. Since then, she has achieved a better work-life balance, putting in 26-28 hours a week. Miller now spends more time with her kids and in her additional role as an executive coach to leaders in the medical field.

More Focus: "When I'm at work, I'm 100% mentally in and focused," said Miller. "My interactions with patients are different because I'm not burned out. My demeanor and my willingness to connect are stronger."

Better Health: Mehmet Cilingiroglu, MD, with CardioSolution, traded full-time work for part-time when health issues and a kidney transplant sidelined his 30-year career in 2018. "Despite my significant health issues, I've been able to continue working at a pace that suits me rather than having to retire," he said. "Part-time physicians can still enjoy patient care, research, innovation, education, and training while balancing that with other areas of life."

Errin Weisman, a DO who gave up full-time work in 2016, said cutting back makes her feel healthier, happier, and more energized. "Part-time work helps me to bring my A-game each day I work and deliver the best care," she said. She's also a life coach encouraging other physicians to find balance in their professional and personal lives.

Cons

Cut in Pay: Obviously, the number one con is you'll make less working part-time, so adjusting to a salary decrease can be a huge issue, especially if you don't have other sources of income. Physicians paying off student loans, those caring for children or elderly parents, or those in their prime earning years needing to save for retirement may not be able to go part-time.

Diminished Career: The chance for promotions or being well known in your field can be diminished, as well as a loss of proficiency if you're only performing surgery or procedures part-time. In some specialties, working part-time and not keeping up with (or being able to practice) newer technology developments can harm your career or reputation in the long run.

Missing Out: While working part-time has many benefits, physicians also experience a wide range of drawbacks. Goodman, for example, says she misses delivering babies and doing surgeries.Miller said she gave up some aspects of her specialty, like performing hysterectomies, participating in complex cases, and no longer having an office like she did as a full-time ob/gyn.

Loss of Fellowship: O'Connell says she missed the camaraderie and sense of belonging when she scaled back her hours. "I felt like a fish out of water, that my values didn't align with the group's values," she said. This led to self-doubt, frustrated colleagues, and a reduction in benefits.

Lost Esteem: O'Connell also felt she was expected to work overtime without additional pay and was no longer eligible for bonuses. "I was treated as a team player when I was needed, but not when it came to perks and benefits and insider privilege," she said. There may be a loss of esteem among colleagues and supervisors.

Overcoming Stigma: Because part-time physician work is still not prevalent among colleagues, some may resist the idea, have less respect for it, perceive it as not being serious about your career as a physician, or associate it with being lazy or entitled.

Summing it Up

Every physician must weigh the value and drawbacks of part-time work, but the more physicians who go this route, the more part-time medicine gains traction and the more physicians can learn about its values vs its drawbacks.

The rest is here:
Part-Time Physician: Is It a Viable Career Choice? - Medscape

The Grey’s Anatomy and ER Parallels are Obvious But One Is … – CBR – Comic Book Resources

Network Television is no stranger to medical dramas, from the cynical genius offered by Fox's House to the more humorous approach of NBC's Scrubs and everything in between. As much as the police procedural has been a staple of television, viewers have long since proven themselves to be engaged in the happenings of hospital life too. Perhaps the most successful instances of audience captivation are seen in ER and Grey's Anatomy, which boast high ratings of over 38 million viewers for their top episodes. However, despite their similarities in the rankings department, ER takes the crown for the best rendition of a medical show.

Currently sitting at 416 episodes, Grey's Anatomy officially surpassed ER as the longest-running medical drama on television in 2019 with its 332nd episode. Although both shows are their own entities and have carved out distinctive spaces within the evolution of network television over the last twenty years, ER remains the superior medical drama to this day.

RELATED: Station 19 Ignites a Much-Needed Slow-Burn Romance for Marina

While Grey's Anatomy offers a wide scope in the halls of the hospital, often providing viewers with moments for an intersection between different departments, ER widened the net to provide a larger worldview on medicine. From the backstory painted by Dr. Luka Kovac of life in Croatia to John Carter's trips to Africa, ER allowed viewers to see the struggles of medicine in other parts of the world. On the other hand, Grey's Anatomy remains insular in this field by rarely leaving Seattle, let alone America. Even when Meredith and Amelia spent time in Minnesota for a small stint of research work, the set is not wildly different from Seattle Grace's white walls and state-of-the-art technology.

Additionally, the medical jargon spewed out by characters in ER left little room for doubt that the characters knew exactly what they were talking about and subsequently doing in moments of trauma. Faith was bestowed upon the actors in ER that they could handle themselves in a real emergency. This faith was furthered by the broader perspective shifts when the episodes showcased traumas and medical emergencies outside Chicago.

Furthering the parochialism, Grey's Anatomy heightens the drama by utilizing major disasters. Viewers are encouraged to become entangled in plane crashes, hospital explosions, ferry crashes, shootings, and natural disasters regularly, often overriding the stories of the patients and the doctors. Conversely, ER took a more localized approach and highlighted the chaos of every day in an emergency room setting; the world around County General did not need to be on fire for the episodes to feel high-stakes. The personable storylines allowed viewers to entrust their attention to the show while remaining enveloped in reality. Every patient brought their own catastrophe, which grounded ER in this respect as it mirrored the conflict and emotionally fraught moments of humanity.

RELATED: Grey's Anatomy Empowers Bailey in Meaningful Abortion Care Storyline

Romance is another element that remained parallel with reality in ER as they adhered to the notion of not letting relationships get in the way of the medicine, which juxtaposes with Grey's Anatomy, where they try not to let the medicine get in the way of romance. In the show's fifteen-season run, ER had little more than a handful of relationships between co-workers within the halls of County General -- with Dr. Doug Ross and Nurse Carol Hathaway quickly setting the tone for a slow-burn progression. However, Grey's Anatomy has submitted to the idea that medical professionals spend more time hooking up in on-call rooms than they do treating patients. It's hard to keep track of who is with whom from one week to the next at Grey Sloane Memorial, with the romance on the show losing its appeal due to its frequency.

This is not to say that Grey's Anatomy has not blazed several trails in its own right -- the show is popular and long-standing for a reason -- but it progresses on a path forged by ER. Ultimately, for viewers, ER offered a glimpse into the life of an emergency room, striking an enjoyable balance between the severity of medical emergencies and the more light-hearted elements. Grey's Anatomy relies on its soap operatic tendencies and romantic entanglements too much, whereas ER favored the complexities that impair the fabric of life.

Originally posted here:
The Grey's Anatomy and ER Parallels are Obvious But One Is ... - CBR - Comic Book Resources

The Effects of High-Protein Diets on Kidney Health and Longevity

Although high-protein diets continue to be popular for weight loss and type 2 diabetes, evidence suggests that worsening renal function may occur in individuals with-and perhaps without-impaired kidney function. High dietary protein intake can cause intraglomerular hypertension, which may result in kidney hyperfiltration, glomerular injury, and proteinuria. It is possible that long-term high protein intake may lead to de novo CKD. The quality of dietary protein may also play a role in kidney health. Compared with protein from plant sources, animal protein has been associated with an increased risk of ESKD in several observational studies, including the Singapore Chinese Health Study. Potential mediators of kidney damage from animal protein include dietary acid load, phosphate content, gut microbiome dysbiosis, and resultant inflammation. In light of such findings, adopting current dietary approaches that include a high proportion of protein for weight reduction or glycemic control should be considered with care in those at high risk for kidney disease. Given the possibility of residual confounding within some observational studies and the conflicting evidence from previous trials, long-term studies including those with large sample sizes are warranted to better ascertain the effects of high protein intake on kidney health.

Keywords: chronic kidney disease; glomerular hyperfiltration; high protein diet; nutrition; proteinuria.

See the original post here:
The Effects of High-Protein Diets on Kidney Health and Longevity